Call Now For a Free Consultation:
(614) 532-4576
Nationwide Representation

Aegis Capital Corp. & Representatives Implicated in Microcap Stock Scheme

FINRA has named Aegis Capital Corp., Charles D. Smulevitz (CRD# 5099387), and Kevin C. McKenna (CRD# 1343870) in a complaint concerning a microcap stock scheme. FINRA filed disciplinary proceedings against Aegis Capital Corp., Charles D. Smulevitz, and Kevin C. McKenna in August 2014. The respondents submitted an offer of settlement in July 2015, which FINRA recently accepted.

FINRA's complaint against Smulevitz and McKenna concerns alleged misconduct while the two were registered with Aegis as Chief Compliance Officer.

  • Smulevitz was registered with Aegis from June 1, 2009 until his termination on July 20, 2012.
  • McKenna has been registered with Aegis since June 9, 2010.

According to FINRA’s findings, the misconduct took place between April 2009 and June 2011 when Aegis generated more than $1 million in commissions through illicit sales. FINRA accused Aegis of selling shares that were not registered with the SEC even though registration was required.

FINRA says that a third party, ML, who was not affiliated with Aegis, referred customers to Aegis and controlled activity in many customers’ Aegis accounts. It is important to note that, at the time, ML had already been the subject of three regulatory actions – two of which are relevant to the conduct set forth in this complaint.

Back in 2008, ML had been charged by the SEC with aiding and abetting securities fraud. This is the same type of misconduct that allegedly took place in this case. In 2009, the SEC banned ML from participating in penny stock offerings. A month later, ML was barred completely from the securities industry.

Allegedly, the microcap stock sales in this case were part of a larger plan to evade the SEC’s registration requirements. The SEC accuses Aegis, Smulevitz, and McKenna of failure to establish, enforce, and maintain an adequate supervisory system at the firm to prevent non-compliance with Section 5 registration requirements.If you invested with Aegis Capital Corp. between April 2009 and June 2011 and you lost a substantial amount of money, we invite you to contact the securities fraud lawyers at Meyer Wilson to tell us what happened. We will provide you with a free review of your case to inform you of your legal rights and options.

The information contained in The Firm’s posts on its blog, fraud alerts, investigations or elsewhere on the site is based upon information obtained from other sources including, but not limited to, news outlets and federal, state, and regulatory agency filings. All suspects and subjects of postings herein are presumed innocent until proven guilty in a court of law or administrative action and any and all crimes are alleged until a court or regulatory agency finds otherwise .

Share This Story
If you found the information provided by this article useful, consider sharing to your social media channels to help others in their search for reliable resources.
Consult with Our Legal Team
There is never a cost associated with a consultation
Atlanta Office

945 East Paces Ferry Road, Suite 2275
Atlanta, GA 30326
Columbus Office

305 W. Nationwide Blvd
Columbus, OH 43215
Meyer Wilson
New Orleans Office

900 Camp Street 
Suite 337
New Orleans, LA 70130
Los Angeles Office

2029 Century Park East,
Suite 400N
Los Angeles, CA 90067
Cleveland Office

4781 Richmond Rd.
Suite 400
Warrensville Heights, OH 44128
Bloomfield Hills Office

41000 Woodward Ave.,
Suite 350
Bloomfield Hills, MI 48304
Quick Links
The information contained in this Website is provided for informational purposes only, and should not be construed as legal advice on any subject matter. No recipients of content from this site, clients or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the recipient's state. Read More
The information contained in this Website is provided for informational purposes only, and should not be construed as legal advice on any subject matter.
Read More
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram